Tag: ASCI

  • Misleading ads’ celebrity brand endorsers may be penalised

    NEW DELHI: The Government has said that a Parliamentary Committee’s recommendation of penalties against against endorsers of misleading advertisements was under consideration.

    The Parliamentary Standing Committee on Food, Consumer Affairs and Public Distribution had recommended a fine of Rs One million and imprisonment up to two years or both for first time offence and fine of Rs 5 million and imprisonment for five years for the second time offence for celebrity endorsers.

    The Committee had made the recommendation while examining the Consumer Protection Bill 2015, minister of state for consumer affairs, food and public distribution C R Chaudhary told the Parliament.

    The Committee had recommended stringent provisions to tackle misleading advertisement as well as to fix liability on endorsers / celebrities.

    Replying to another question, he said the Department of Consumer Affairs has launched a portal “Grievance against Misleading Advertisement (GAMA)” where a consumer can lodge a complaint against a misleading advertisement.

    4400 plaints of misleading ads since Mar ’15

    A total of 4438 complaints have been received since March 2015 through this portal. The Advertising Standards Council of India (ASCI) processes these complaints according to its Code.

    The ASCI and the Ministry had signed a memorandum of understanding in this regard.

    If a complaint is upheld, ASCI takes up the complaint with the company / agency concerned either for withdrawal or modification of the advertisement. In case of non-compliance of its orders, ASCI forwards the complaints to the regulators concerned for taking appropriate action.

    ALSO READ :

    Telecast of Amul’s misleading frozen dessert ad suspended

    Over 250 complaints of misleading ads about AYUSH products since Jan 2015

    Healthcare products lead in ASCI norms breach, 143 complaints upheld

    March: Max plaints against healthcare & education sector upheld by ASCI, news channels in list of 214

     

  • 11% TV & 7% digital ad growth in ’16, says Smriti Irani

    11% TV & 7% digital ad growth in ’16, says Smriti Irani

    NEW DELHI: The ministry of information and broadcasting received a total of 280 complaints on misleading advertisements during the period 2015 to 2017 as on 30 June, the Parliament has been told.

    Information and broadcasting minister Smriti Irani said an advisory had been issued by the ministry on 21 August 2014 advising all TV channels not to telecast advertisements, which were found to be violating provisions of Cable Television Networks Rules, 1994, the Advertising Standards Council of India Code and also Drugs & Magic Remedies (Objectionable Advertisement) Act 1954.

    Irani said the report of Indian media and entertainment industry 2017 released by Federation of Indian Chambers of Commerce and Industry (FICCI-KPMG) showed that there was a total growth of 11.2 per cent in 2016 as compared to 2015 in advertising in the industry. Of this, there was a growth of 11 per cent in television and seven per cent in digital advertising in 2016 over 2015.

    The Department of Consumer Affairs has established a ‘Grievances against Misleading Advertisement’ (GAMA) portal, through which a common man can lodge a complaint against misleading advertisements. These complaints are processed by Advertising Standards Council of India (ASCI) under an MoU with the department of consumer affairs.

    The total number of incidents/complaints received by department of consumers during the 2015-16 to 2016-17 is 3368.

    The ASCI self-regulates advertising content to monitor and decide on complaints against advertisements making misleading, false and unsubstantiated claims.

    Also Read:

    Smriti Irani gets additional charge as MIB minister

    Guest Column: M&E industry in India: 5 not-to-be-missed trends

     

  • March: Max plaints against healthcare & education sector upheld by ASCI, news channels in list of 214

    MUMBAI: Although a maximum number of complaints upheld by ASCI were in the healthcare sector, tow of the news channels — TV Today (Aaj Tak) and TV 18 Broadcast (CNN News 18) also figured in the list against which complaints were upheld. ASCI’s Consumer Complaints Council (CCC), in March 2017, upheld complaints against 214 out of 280 advertisements. Of the 214 advertisements against which complaints were upheld, 175 belonged to the Healthcare category, 21 to the Education category, followed by seven in the Food & Beverages category and 11 advertisements from other categories.

    TV Today Network Ltd. (Aaj Tak): The advertisement’s claim, “Aaj Tak’s urban viewership crossed India TV’s All India Viewership” – Source : BARC, 08 Nov 16, TG 15+ NCCS AB, Time Band 2000-2400, imp’000, was not acceptable. It was noted that as per the recently circulated guidelines for Single Event reporting, the announcement of demonetization could be considered as single event reporting. However, the advertiser did not provide any data to show that impressions delivered are 25% above the same time band average for the previous four weeks or that impressions delivered are more than 20% of the full day impressions on the specified day, which is required as per the specific criteria in the BARC guidelines on Single Event reporting. This was in violation of the BARC principles and specific criteria for single event reporting.

    TV18 Broadcast Ltd. (CNN News18): The advertisement had the visual representation of charts suggesting the claims, “CNN-News18 is the No.1 English News Channel”. It was noted that the chart used in the advertisement violates the ‘Visual Representation’ Guidelines –   “Visual representations help the intended recipient of a commercial message. They must adhere to the following principles – Axes of a graph must be orthogonal, at 90°, Scaling must be linear, The Y-axis must generally intercept the X-axis at value 0. If an alternative value is used, this must be clearly indicated both on the chart and in its legend.” Though the complaint of misleading comparison was not considered to be objectionable, the visual representation shown is not in compliance with BARC Guidelines and therefore represents a misleading comparison. 

    HEALTHCARE:

    The CCC found the following claims of 175 advertisements in health care products or services to be either misleading or false or not adequately / scientifically substantiated and hence violating ASCI’s Code. Some of the health care products or services advertisements also contravened provisions of the Drug & Magic Remedies Act and Chapter 1.1 and III.4 of the ASCI Code. Complaints against the following advertisements were UPHELD.

     

      1.         Kolors Health Care India Pvt. Ltd. (Kolors Slimming & Beauty): The advertisement’s claim, “Five kilograms weight loss guarantee and five inch figure correction”, was inadequately substantiated and is misleading by gross exaggeration.  The efficacy being depicted via images of before and after the treatment is misleading by gross exaggeration.

     

      2.        Ayurwin Pharmaceutical Pvt. Ltd. (Nutrigain plus Powder & Capsules): The advertisement’s claims, “The only weight gain Product Powered by Ayurscience” and “Approved by Ayush Dept.”, were not substantiated with supporting evidence, and are misleading by gross exaggeration.

     

      3.       SBS Biotech (Dr Juneja’s Accumass): The advertisement’s claims, “Accumass is very helpful to gain weight”, “Increase body weight, not fat”, and pack claim, “Ayurvedic Formulation to help Gain Weight for all ages”, were not substantiated with supporting clinical evidence of product efficacy, and are misleading by exaggeration. Further the claims, “World’s Greatest Brands 2015-16 IUA” and “World Brand Summit – Most Trusted Brand of Asia 2016”, were not substantiated with any support data of the research or any comparative data versus other similar brands in the same category. The claims are not qualified to mention the source and date of research and criteria for assessment for the claims made. Also, the claims are misleading by ambiguity and omission.

     

      4.         SBS Biotech Ayurvedic Division (Roop Mantra  Skin Care Products): The advertisement’s claims, “World’s Greatest Brands 2015-16 IUA”, “India’s Most Trusted Brand – Consumer Validated 2015 – Voted By Indian Consumers”,  “Selected No.1 Brand India 2014 – Consumer Survey Report, Mrg 2014”, “World Brand Summit Dubai 2016 (Ayurvedic Otc Products) Conducted By : World Brands Review Corporation”, “Most Trusted Brand Of Asia 2016”, were not substantiated with any support data of the research or any comparative data versus other similar brands in the same category. The claims are not qualified to mention the source and date of research and criteria for assessment for the claims made. Also, the claims are misleading by ambiguity and omission of the product category. 

     

      5.          Dr. Batra’s Positive Health Clinic (Dr. Batra’s Homeopathy): The advertisement’s claims, “Our treatment results are independently audited by American Quality Assessors (AQA) across our patient base of 15 lakh, and are as follows: – All Ailments – 94% Better – Hair Loss – 95% Better – Skin Diseases – 88% Better – Women’s Problems – 94% Better – Child Disorders – 94% Better”, were not substantiated with authentic supporting evidence nor any independent audit or verification certificate, and are misleading by exaggeration. 

     

      6.          Dr Batra’s Homeopathic Clinic: The advertisement’s claims, “We have successfully treated more than ten lakh patients having Skin conditions, Women’s disease, High sugar levels,  Overweight, Sexual Problems, in every age person” and the visual implying cure of Leucoderma are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

      7.          Ayushakti Ayurved Pvt. Ltd. (Ayushakti Ayur Health Centre): The advertisement’s claims, “Even the Phoenix House Foundation in the U.S.A. believes Ayushakti doctor are the best in giving solutions for breathlessness, allergies and depression”, “Ayushakti helped rescue workers of 9/11 attack to come out of shock, depression, severe breathlessness, joints pain and chronic fatigue”, “Within 18 months 80% of the people did not need any breathing pumps. Their frequent allergy problems, breathlessness and depression had relieved remarkably and they all started working again”, “The Phoenix House Foundation U.S.A research proves Ayushakti herbs are effective in combating breathing difficulties, joint pain, chronic fatigue and depression”, “In general, Ayushakti’s herbs proved to be the most effective after six months!”,  “Continuing the  rejuvenation herbs in the Asthatox program, helps nourish the channels, thus protecting your lungs from further damage and promotes easy breath” and “Asthatox detox provides remarkable results in just two months. If you follow only herbs and diet, then you get relief from symptoms in six months to a year”, Ayushakti has helped lacs of people for the past 27 years to relieve chronic ailments like joint pain, breathlessness, high blood sugar, skin and hair problems, gas -acidity, IBS, weight gain, unable to experience parenthood”, were inadequately substantiated and are misleading by gross exaggeration.

     

      8.          Kalpayur Ayurvedic Clinic & Panchakarma Center (Diabecare): The advertisement’s claim, “Diabecare – Natural & Effective Support in Diabetes. Yogic Naturals with Active Nano Extracts”, was not substantiated with supporting clinical evidence and is misleading.

     

      9.           Simandar Herbal Pvt. Ltd. (Yesaka Sugar Free Liquid): In the advertisement’s claim, the product name, “Yesaka Sugar Free Liquid” for product meant for treatment of diabetes, is misleading by implication. The product name when read in conjunction with the tagline, “curing naturally” and visual showing a Glucometer,  implies that the product is beneficial in curing diabetes, which is in breach of the law as it violated the Drugs & Magic Remedies Act (DMR Act).

     

      10.         The Pain Clinic: The advertisement’s claim (in Gujarati) as translated into English, “Treatment without operation”, was not substantiated with clinical evidence of the treatment efficacy and is misleading by gross exaggeration. 

     

      11.          Prettislim Clinic: The advertisement’s claim, “Winner of Best Healthcare Brand 2016 Award” was inadequately substantiated and the claim is misleading by omission and ambiguity. Further for the claim, “No1 slimming Clinic in Mumbai”, while the advertiser presented reference of All India Lifestyle Hospitals and Clinic survey 2016 mentioning Prettislim as No.1 Bariatric clinic, its mention as No. 1 slimming clinic was not considered acceptable and was considered to be misleading by ambiguity. Also the claim, “Thousands of satisfied customers who have given us 95% satisfaction ratings”, it was noted that the data provided by the advertiser is self-certified. In absence of any third party validation, this data was not considered to be unbiased and reliable.

     

      12.          Slim Trim Point: The advertisement’s claims, “Five kilograms + 20-25 centimeters in six hours”, “Ten kilograms + 35-40 centimeters in 12 hours”, “20 kilograms + 55-60 centimeters in 24 hours”, were not substantiated with supporting clinical evidence, and with treatment efficacy data,  and are misleading by exaggeration.

     

      13.          GEHM Clinic and Research Center (Fit Forte Tablets): The advertisement’s claim, “Fit Forte Tablets -To reduce body weight”, was not substantiated with evidence of product efficacy, and is misleading. Visual shown in the advertisement implies significant weight loss, which is misleading by implication. 

     

      14.          Eye-Q Vision Ltd.: The advertisement’s claims, “Most Trusted Brand” was inadequately substantiated. The claim does not cite the source and date of research and is misleading by omission of the mention of the sub-category for the award.

     

      15.           Lifezen Pvt. Ltd. Healthcare: The advertisement’s claims, “Better QUALITY  Better RELIEF  Better PRICE”, were not substantiated with verifiable comparative data versus other similar products in the same category, and are misleading by exaggeration and implication that other eye drops products are inferior to the advertised product.  

     

      16.           Shahjadi Pharmaceutical Private Limited (Ab Love Day): The advertisement’s claims, “Ab Love Day- Trusted, Effective and Convenient”, “Two tablets keeps you from getting pregnant for six months”, “Freedom from regular intake of tablets” and “Safe, Effective and Easy way to keep age gap between children”, were not substantiated with clinical evidence, and are misleading by gross exaggeration.

     

      17.            Chemical Resources (GCB 70): The advertisement’s claims, “Better Body, Better Life”,  “Burn both sugar and fat & slow the release of sugar into blood stream”,  “Preserve natural antioxidants in the body”,  “Decrease waist circumference & BMI”,  “Clinically Evaluated”  and “GCB 70 supports healthy metabolism”, were inadequately substantiated.  Also, the claims are misleading by ambiguity and implication. 

     

      18.             Yashna Enterprises (No Blu Glasses): The advertisement’s claims, “Get 5X Sharper Visual Detail and 10X Reduced Eye Strain!” were not substantiated and are misleading by gross exaggeration.

     

      19.             GBR Clinic-Fertility Centre: The advertisement’s claims, “Being the No.1 Fertility Clinic in Chennai & Tamil Nadu, we have been providing very high success rate consistently every month”. It was noted that the advertiser has not provided any authentic, independent, verifiable comparative data versus other similar clinics in the same category or any third party validation or research to prove this claim, and the claim is misleading by exaggeration and implication that they would cure infertility. Additionally, this is in breach of the law as it violated the DMR Act.  

     

      20.              Vaidya Revati Prasad (112 salki burhia ki ghuti): The advertisement’s claims, “Enriched with calcium & iron” and “Makes children healthy & strong”, were inadequately substantiated with evidence of product content analysis and efficacy.  Also, the claims are misleading by ambiguity.

     

      21.              OPTM Health Care (P) Ltd. (UR Halt): The advertisement’s claims, “URHALT- Control Naturally” and “Presenting URhalt – clinically evaluated, natural oil that can regain control of your overactive bladder”, were inadequately substantiated and are misleading by exaggeration.  

     

      22.               Ayurved Sumshodhanalaya Pvt. Ltd. (Kailas Jeevan multipurpose Ayurvedic cream): The advertisement’s claims, “Take a teaspoonful of K J Cream with equal amount of ground sugar before bed time.  Brings relief from piles” and “Effective on burning sensation in Burns, Wounds and Cuts also” were inadequately substantiated, and are misleading.

     

      23.               Gaudium IVF Centre (Gaudium Kare IVF): The advertisement’s claims, “Delivering highest success rate across the Country”, was not substantiated with verifiable comparative data versus other similar clinics in the same category or any third party validation or research to prove this claim. Further the claim, “High Success rate even in failed IVF cases”, was not adequately substantiated with supporting data.  Also, the claims are misleading by gross exaggeration and implication of assured child for childless couples. It was also considered that the advertisement with reference to infertility “treatment” was in violation of the DMR regulations / The Drugs & Cosmetics Rules (D&C Act).

     

      24.               Srikara Hospital: The advertisement’s claim, “No.1 Centre for OXINIUM Knee Replacements”, was not substantiated with any verifiable comparative data versus other similar clinics in the same category or any third party validation or research, and is misleading by exaggeration. 

     

      25.               Manjeeram Holistic Centre:  The advertisement’s claim, “Provides treatment for any kind of diseases without any medicine”, was not substantiated with supporting clinical evidence, and with treatment efficacy data among patients, and is misleading by gross exaggeration.

     

      26.              Kudos Laboratories India Limited (V-1 Capsules and Jointment): The advertisement’s claim, “First time the most-cheapest solution for joint pains in India”, was not substantiated with comparative data versus other similar products in the same category. Further the claim, “Does not have side effect”, was considered to be an absolute claim and was not substantiated with clinical evidence. The claims, “Lac of people have accepted the tablet”, was not substantiated with supporting data. Also, the claims are misleading by gross exaggeration. The claims referring to Central Ministers praising the product, and Government of India letter endorsing the product, were misleading by ambiguity and were in violation of the Emblems and Names (Prevention of Improper Use) Act. The testimonials used in the advertisement imply cure from arthritis and were in contravention of the DMR Act.

     

      27.              Kudos Ayurveda (Kudos Maharaja): The advertisement’s claims, “Now more power”, “Get Back the Fire”, “Kudos Maharaja makes married life more exciting” and the visual in the advertisement and package, read in conjunction with the claims made in the advertisement imply that the product is meant for enhancement of sexual pleasure and are considered to be, prima facie, in violation of the D&C Act.

     

      28.             Kudos Laboratories India Limited (Kudos V1 Capsule and Jointment): The advertisement’s claims, “If you want to say goodbye for joint pain then now accept V1 (14:47)” and “Complete treatment for joint pain (00:53)” and the visual in the advertisement (2:08 and 17:03 -For Rheumatoid Arthritis V1) implies that the product is meant for treatment / cure of Rheumatism. This is considered to be, prima facie, in violation of the DMR Act.

     

      29.              Jeewan Jyoti Pharmacy Pvt. Ltd. (Health Sun Range Of Products): The advertisement’s claims, “If you are thin then don’t be sad, Health sun capsules and powder helps to eliminate your thinness, Repairs blood circulation and helpful in increasing weight by removing lack of mental and physical development”, “Increase body weight not fat” and “Health sun capsules and powder helps to eliminate your thinness and Repairs blood circulation and bring body in shape and beautiful”, were not substantiated with supporting clinical evidence of product efficacy. Further the claims, “This is trusted certified Ayurvedic Medicine and is fully safe”, was not substantiated with supporting data. Also, the claims are misleading by exaggeration.

     

    30.               Trophic Wellness Pvt. Ltd. (Nutricharge – Man Tablet): The advertisement’s claims, “Helps meet daily needs of Vitamins and Minerals”, “Provides 35 vitamins, minerals, amino acids and antioxidants”,  “Provides most vital nutrients in required quantity to prevent nutritional deficiencies, helps to maintain function and structure of various organ systems and may be beneficial for cardiovascular health and in diabetes”,  “not harmful for a person with diabetes”,  “Works specifically for correcting dietary deficiencies only and does not increase weight “,  “Non habit forming” and “May be beneficial if you are on a special diet or dieting as it provides valuable vitamins, minerals and amino acids which you may not get from your strict diet”, were not substantiated with clinical evidence or proof of efficacy for the product, and are misleading by exaggeration.

     

      31.            Trophic Wellness Pvt. Ltd. (Nutricharge Prodiet): The advertisement’s claims, “Contains high quality Soy protein isolate from DuPont USA, dietary fiber from Matsutani, Japan and cocoa from Belgium”, “Take 1 tablet of Nutricharge Man with 1 glass of Nutricharge ProDiet shake, in the morning to fulfill your daily needs of Protein, Vitamins, Minerals and Fiber”,  FAQ: “being an excellent source of protein can be taken daily in recommended dose to help fill the gap in our protein nutrition”, FAQ: “provides hi-quality purified and processed soya protein which may help enhance physical strength and boost immunity. For getting all key minerals and vitamins adults should take one tablet of Nutricharge Man/ Woman also daily” and FAQ: “an excellent supplement containing high quality protein besides iron, folic acid and calcium”, were not substantiated with supporting proof, and are misleading.

     

      32.            Trophic Wellness Pvt. Ltd. (Nutricharge Kids): The advertisement’s claims, “For the first time in India, a special chocolate flavoured supplement for children that contains 49 nutrients” and “Three type of protein, 15 vitamins, 14 minerals, fiber, ten botanicals other macromolecules, three pre-pro biotics and two amino acids.”, were not substantiated with supporting data. Further the claim, “It helps in improving brain development, boost immunity and promote growth”, was not substantiated with evidence of product efficacy. Also, the claims are misleading by exaggeration.

     

      33.            Trophic Wellness Pvt. Ltd. (Nutricharge Health Drink): The advertisement’s claims, “Energy revitalizing beverage”, “Enriched with Minerals and Electrolytes to hydrate the body”, “Energy boosters like Taurine and Vitamins” and “One can consume it when one feels low on energy, de-hydrated, refreshment and thirst”, were not substantiated with proof of efficacy. Further the claim, “Contains natural Pomegranate and Red Grape juice from USA and Spain”, was not substantiated with supporting data. Also, the claims are misleading by exaggeration.

     

      34.            Trophic Wellness Pvt. Ltd. (Nutricharge): The advertisement’s claims, “Clinical Trials prove Nutricharge efficacy and safety” and “Nutricharge products are health supplements “ were not substantiated and are misleading.

     

      35.            Trophic Wellness Pvt. Ltd. (Nutricharge Products): The advertisement’s claim, “The Most Awarded Wellness Brand”, is an absolute claim and is not substantiated with any comparative data versus other brands, and is misleading by exaggeration.

     

      36.            Shree Baidyanath Ayurved Bhawan Pvt. (Baidyanath Arjunamrita): The advertisement’s claims, “As Arjunamrut is enriched with herbs like Naagkeshar and Lotus Flower it is more beneficial” and “More Effective than Ordinary Arjunarishta”, were not substantiated with product efficacy data, and are misleading by exaggeration.

     

      37.            Shree Baidyanath Ayurved Bhawan (Baidyanath Vita Ex Gold Plus): The visual in the advertisement and the product packaging read in conjunction with the claims in the advertisement implies that the product is meant for enhancement of sexual pleasure which is considered to be, prima facie, in violation of the D&C Act.

     

      38.            Shree Kalyan Ayurvedashram: The advertisement’s claims, “Acclaimed by thousands of patients having suffering from spots” and “After starting treatment the color of spots change & instantly all spots get removed and skin color gets uniform”, are considered to be, prima facie, in violation of the DMR Act and D&C Act.

     

      39.           Shree Maruti Herbal (Stay On Power Capsules): The advertisement’s claim, “Effective for Energy, Excitement and Power” and the visuals in the advertisement, product packaging and product name read in conjunction with the claim in the advertisement imply that the product is meant for enhancement of sexual pleasure, is considered to be, prima facie, in violation of the D&C Act.

     

      40.           Shree Maruti Herbal (Stay On Oral Liquid): The visuals and claims in the advertisement imply that the product is meant for enhancement of sexual pleasure. The advertisement is considered to be, prima facie, in violation of the D&C Act.

     

      41.          Shree Maruti Herbal (Stay-On Power Oil): The advertisement’s claim, “Massage daily and experience the height of happiness Only for Men” and the visual in the advertisement and package, read in conjunction with the claims objected to imply that the treatment is meant for enhancement of sexual pleasure and are considered to be, prima facie, in violation of the D&C Act.

     

      42.          Shree Maruti Herbal (Stay on Power Capsule): The advertisement’s claim, “Feeling of Strength and Absolute Vigour” and the visuals in the advertisement read in conjunction with the claim objected to imply that the product is meant for enhancement of sexual pleasure is considered to be, prima facie, in violation of the D&C Act.

     

      43.          Shree Maruti Herbal (Stay on Power Capsules): The advertisement’s claim, “This is the opportunity to give energy to the sperms” and the visuals in the advertisement, product packaging and product name read in conjunction with the claim objected to, imply that the product is meant for enhancement of sexual pleasure, is considered to be, prima facie, in violation of the D&C Act.

     

      44.           Shree Maruti Herbal (Stay on Power Capsules): The advertisement’s claim, “Feel the power. Hour – after – hour” and the visuals in the advertisement, product packaging and product name read in conjunction with the claim in the advertisement imply that the product is meant for enhancement of sexual pleasure, is considered to be, prima facie, in violation of the D&C Act.

     

      45.         Shree Maruti Herbal (Stay on Power Capsules): The advertisement’s claim, “Helpful for Energy, Excitement and Power” and the visuals in the advertisement, product packaging and product name read in conjunction with the claim in the advertisement imply that the product is meant for enhancement of sexual pleasure, is considered to be, prima facie, in violation of the D&C Act.

     

      46.         Shree Maruti Herbal (Stay On Power Capsules): The advertisement’s claim, “Effective for Energy, Excitement and Power” and the visuals in the advertisement, product packaging and product name read in conjunction with the claim in the advertisement imply that the product is meant for enhancement of sexual pleasure, is considered to be, prima facie, in violation of the D&C Act.

     

      47.         Shree Maruti Herbal (Stay On Oral Liquid): The visuals and claims in the advertisement imply that the product is meant for enhancement of sexual pleasure. The advertisement is considered to be, prima facie, in violation of the D&C Act.

     

      48.         Shree Maruti Herbal (Stay On Power Oil): The advertisement’s claims, “Physical Deficiency? Lack of Excitement? Loose Organ? Strengthen the loose organs and helps to make fresh sperm counts”, “Massage daily and experience the HEIGHT of HAPPINESS” and the visuals in the advertisement, product packaging and the product name read in conjunction with the claims objected to imply that the product is meant for enhancement of sexual pleasure, were considered to be, prima facie, in violation of the D&C Act.

     

      49.         Shree Maruti Herbal (Stay-On Range of Products): The visuals in the advertisement, product packaging and the product name imply that the product is meant for enhancement of sexual pleasure. The advertisement is considered to be, prima facie, in violation of the D&C Act.

     

      50.         Tasmiya Retail Private Limited (Beauty 4ever Permanent Hair Removal Cream): The advertisement’s claims, “Get rid of unwanted hair through cream”, “For both Women & Men, apply just twice” and “Permanent hair removal cream”, were not substantiated with product efficacy data, and are misleading by exaggeration. Also, efficacy being depicted via images of before and after the use of the product are misleading.

     

      51.        Dr Bhavana Shah Fitness Highway (Vela weight loss, U-Lipo and Tummy tuck): The advertisement’s claim, “Lose ten kilograms in ten weeks”, was not substantiated with supporting clinical evidence, and with treatment efficacy data, and is misleading by exaggeration. There was no reference to Rs. 30,000/- in the package claimed in the advertisement. Further the claim offers, “U-Lipo FREE!!!*”, “Tummy Tuck FREE!!!*” and “Six months maintenance free!!!*”, are misleading by ambiguity and omission as the services offered are not free but subject to purchase of package of Rs.30,000/-.

     

      52.        Dr. Bhavana Shah’s Fitness Care Pvt. Ltd. (Dr. Bhavana Shah’s Fitness Highway): The advertisement’s claims, “Fantastic Results with Signature FAT FREEZEE Crylipolysis”, “Spot Reduction” and “Lose upto eight centimeters to ten centimeters in Fat Freeze*, Lose upto 1/2 kg to 1 kg in Fat Freeze*”, were not substantiated with supporting clinical evidence, and with treatment efficacy data, and are misleading by exaggeration.  The visual of a slim waistline in the advertisement was considered to be misleading by implication.

     

      53.        Dr. Mehul’s The Slimming Clinic (The Slimming Clinic): The advertisement’s claim (in Gujarati), as translated into English, “Weight loss upto six kilograms in one month & fifteen centimeters in one session”, was not substantiated with supporting clinical evidence, and with treatment efficacy data,  and is misleading by exaggeration.

     

      54.       Angels Advanced Clinic Private Limited (Angels Advanced Clinic): The advertisement’s claims, “Want to Improve Entire Body Colour Complexion?-First time in India, Angels introduced, Proven World Class GSH Technology. Make your dream of improving Entire Body Colour come true” and “For Dense Hair Stem Cell Therapy  Angels STEMCELL Therapy which is a Universal Technology controls Hair fall, not only prevents Bald Head but also brings new hair growth for hair thinning and semi bald head”, were not substantiated with clinical evidence and with treatment efficacy data, and are misleading by gross exaggeration. The efficacy being depicted via images of before and after the treatment are misleading by gross exaggeration.

     

      55.      High Hopes: The advertisement’s claims (in Gujarati), as translated into English, “No Exercise  No Gym”,  and “Reduce weight upto 10 kg in 3 months through scientific Method”, were not substantiated with supporting clinical evidence, and with treatment efficacy data,  and are misleading by exaggeration. The efficacy being depicted via images of before and after the treatment is misleading by gross exaggeration.

     

      56.      Zee Laboratories Limited (Zee Myfair Cream): The advertisement’s claim, “President Award Winner”, was not substantiated with details of the award and references of the award received such as the year, source and category. Further the claim, “India’s Most Favourite”, was not substantiated with any verifiable comparative data versus other similar fairness creams in the same category or any third party validation or research to prove this claim.  Also, the claims are misleading by exaggeration. 

     

      57.      Life Homeopathy: The advertisement’s claim, “Without Operation: Piles, Fistula, Tumours” and the misleading testimonial which implies cure for asthma, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

      58.     Sardar Ji Skin Cure: The advertisement has reference to White Spots (vitiligo). It is misleading by ambiguity and implication and is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

      59.     Lord Pharma Company (Mehanorm Plus): The advertisement’s claim, “Sure treatment of diabetes”, is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

      60.     Sun Laboratories (P) Ltd. (Titanic-K2 Capsules): The advertisement’s claims, “Now Titanic-K2 with full energy” and “Power Booster for Men”, are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Ayur Veda Mantra: The advertisement’s claims, “Cure in 14 Days Cervical Spondylosis, Lumbar Spondylosis and Parkinsonism”, are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Mata Tirath Devi Ayurvedic Hospital: The advertisement’s claim, “Ayurvedic treatment of cancer”, is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Dr Shukla Ayurvedic Sex Clinic: The advertisement’s claims, “Meet for masculine weakness, nightfall, premature ejaculation, discharge, childlessness, lack of sperm & every veneral diseases.”, “Get New strength and youth in growing age” and the visuals in the advertisement read in conjunction with the claims in the advertisement imply that the treatment is meant for enhancement of sexual pleasure, and are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Cenozoic Remedies Pvt. Ltd. (Diaba Dops Liquid & Capsules): The advertisement’s claim, “Now sugar treatment from roots”, is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Star Ayurveda (Star Homeopathy/Star Ayurveda): The advertisement’s claims, “Safe, perfect treatment for all types Chronic Health Diseases ….. Treatment without operation. Put an end to Asthama, Obesity, Diabetes, Infertility Problems, Rheumatoid Arthritis, and Ankylosing Spondylitis”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.       Star Ayurveda: The advertisement’s claims, “Guaranteed treatment for all chronic health diseases,” “Permanent Solution for chronic diseases like piles, fissure, fistula, kidney disorders! Along with this special treatment for Neurological Disorders, Liver and Digestion related problem without operation,” and “Joint Pains, Sciatica, Adenoids, Spondylitis, Tonsils, Stones in Kidneys” are considered to be, prima facie, in violation of the DMR Act and D&C Act.

     

    1.       Star Ayurveda (Star Homeopathy): The advertisement’s claim, “Cervical Spondylitis, Arthritis, Piles, Fissures, Fistula, Kidney Stones- No Operation, No Pain Killers,” and the claims imply cure from these conditions. This is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.       Star Ayurveda (Star Homeopathy): The advertisement’s claim, “Solution without operation for chronic diseases like piles, fissure, fistula, Spondylitis, Stones in Kidney,” is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.     Charak Kayakalp Hospital: The advertisement’s claims, “Get rid of Asthma quickly” and “Kidney failure patients are taking benefits through panchkarma treatment and getting rid of dialysis”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Olivet Pharma Pvt. Ltd. (Ayusya Ayurvedic Super Speciality Treatment): The advertisement’s claims, “Get a pain free life with the process of ayurvedic Panchakarma, treat Rheumatoid Arthritis, Psoriatic Spondylitis, Cervical and Lumber Spondylitis and Leucoderma”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Soliel International Healthcare Products (BT-36 Body toner capsule and cream): The advertisement’s claim, “Beautiful shape” and the visual in the advertisement, read in conjunction with the claim objected to, imply that the product is meant for breast enhancement. The claim is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Positive Homeopathy: The advertisement’s claims, “Excellent Safe treatment by experts in skin disease. To any problem, easy and safe process treatment- Infertility Piles, Diabetes, Spondylitis”, “Complete cure of diseases with nano pills-Diabetes, Piles, Arthritis, Infertility, Hepatitis”, “100% Cure is our priority” and the visual implies cure for Leucoderma, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.       Positive Homeopathy: The advertisement’s claims, “100% Cure is Our Priority”, “Treatment with Nano pills through Advanced Nano Medicine and Genetic Method for the first time in world, Diabetes, Commplete Treatment to Piles, Fistula and Fissures, Hepatitis-B Free from breathing related problems, Asthma Motherhood is Blessing, Make it success, Good solution”, “PCOD, Infertility, Hormones problems, Over Weight”, “End to Sex problems,” “ED problems, Sexual Depression, Hormones,” and “Complete treatment to Piles, Fistula, & fissure” are considered to be, prima facie, in violation of the DMR Act and D&C Act.

     

    1.       Positive Homeopathy:  The advertisement’s claim, “Get rid of from Piles/Fissures/Fistula,” is considered to be, prima facie, in violation of the D&C Act.

     

    1.    Meeta Ayurveda: The advertisement’s claims, “Increase sex time upto 35 minutes”, “Take advice and treatment for penis length/ increase thickness, discharge, thinness, loose organ, sloping organ” and the visual in the advertisement, read in conjunction with the claims objected to imply that the treatment is meant for enhancement of sexual pleasure are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Ayurved Amrutam: The advertisement’s claims, “Successful treatment of patients disappointed by other medical methods- Obesity, Diabetes, Women’s Diseases, White spots, Hepatitis, Liver cyst, Fatty Liver, Venereal diseases, Stomach diseases- Ulcers, Piles, Kidney Stones,” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.       Ayurved Amrutam: The advertisement’s claims, “Successful treatment of patients disappointed by other medical method” and “Relief from the beginning in excessive pain, Cervical, Arthritis, Obesity, Diabetes, White Spots, Liver, Hepatitis, Fatty, Liver, Kidney Stone, Ulcer, Piles, Female Diseases” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Ratan Ayurvedic Sansthan (Sudol Body Toner Capsules): The advertisement’s claims, “It has raised confidence of generations”, “Used by millions of females, Get amazing confidence with sudol” and the package visual implies that the product is meant for breast enhancement are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Raheem Unani Clinic: The advertisement’s claims, “Excellent Treatment for Lost Sexual desires, Masturbation, Quick Ejaculation, Sexual Dissatisfaction, Infertility and other sexual related problems”  and the visual in the advertisement, read in conjunction with the claims objected to imply that the treatment is meant for enhancement of sexual pleasure, treatment without operation, for removal of stones in Kidneys. Also, the visual in the advertisement, implies cure for Leucoderma are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    G M Ayurved: The advertisement’s claims, “Increase height. Two – six inches, course duration four months, result from the first month”, “Remove obesity, Reduce extra fat and weight”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Dr. Dassan’s life Care Ayurvedic Herbal Treatment and Research Centre: The advertisement’s claims, “Patient of hemiplegia          and paralysis who was unable to speak is able to speak again”, “Three months of treatment with Dr. Dassans he has his got speech back and is able to walk again” and the testimonial claims cure for paralysis, are considered to be, prima facie, in violation of the DMR Act and D&C Act.

     

    1.    Dr Dassans Ayur Neuro Treat & Res Cent: The advertisement’s claim, “We can survive from Kidney Disease and Dialysis”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Rajnish Hot Deals Pvt. Ltd. (Play Win Capsule): The advertisement’s claims, “Gives vigour & enormous pleasure” and the visual in the advertisement, imply that the treatment is meant for enhancement of sexual pleasure are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Rajnish Hot Deals Pvt. Ltd. (Playwin Capsule): The advertisement’s claim, “More enjoyment that will make your partner excited, Helps control premature ejaculation” and the visual in the advertisement, read in conjunction with the claims objected to imply that the product is meant for improvement of sexual capacity. These are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Rajnish Hot Deals Pvt. Ltd. (Playwin plus Capsule): The advertisement’s claims, “Increases passion, strength, extra timing and pep” and “helps stop premature ejaculation”, are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Rajnish Hot Deals Pvt. Ltd. (Playwin Capsules): The advertisement’s claims, “Forget the world when you have loads of vigour”, “Increases vigour, strength, Energy & pep!” and the visuals in the advertisement read in conjunction with the claims objected to imply that the product is meant for enhancement of sexual pleasure are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Rajnish Hot Deals Pvt. Ltd. (Playwin Capsules): The advertisement’s claim, “Take pleasure of married life with more vigour,” and the visuals in the advertisement read in conjunction with the claim objected to implies that the product is meant for enhancement of sexual pleasure is considered to be, prima facie, in violation of the D&C Act.

     

    1.       Rajnish Hot Deals Pvt. Ltd. (Playwin Capsules): The advertisement’s claim, “Make your Valentine Day More Special with PLAY WIN,” and the visuals in the advertisement read in conjunction with the claim objected to imply that the product is meant for enhancement of sexual pleasure is considered to be, prima facie, in violation of the D&C Act.

     

    1.       Rajnish Hot Deals Pvt. Ltd. (Playwin Capsules): The advertisement’s claim, “Make your relationship stronger” and the visuals in the advertisement read in conjunction with the claim objected to imply that the product is meant for enhancement of sexual pleasure is considered to be, prima facie, in violation of the D&C Act.

     

    1.       Rajnish Hot Deals Pvt. Ltd. (Playwin Capsules): The advertisement’s claim, “Helps prevent Premature Ejaculation” and the visuals in the advertisement read in conjunction with the claim objected to imply that the product is meant for enhancement of sexual pleasure is considered to be, prima facie, in violation of the D&C Act.

     

    1.       Rajnish Hot Deals Pvt. Ltd. (Playwin Plus Capsules): The advertisement’s claims, “Make your Valentine Day Special with Play Win Plus”, “Make your relationship more stronger” and the visuals in the advertisement read in conjunction with the claims objected to imply that the product is meant for enhancement of sexual pleasure, is considered to be, prima facie, in violation of the D&C Act.

     

    1.       Rajnish Hot Deals Pvt. Ltd. (Playwin plus Capsules): The advertisement’s claim, “The success of happy married life, make your relationship stronger” and the visuals in the advertisement read in conjunction with the claims objected to imply that the product is meant for enhancement of sexual pleasure, is considered to be, prima facie, in violation of the D&C Act.

     

    1.       Rajnish Hot Deals Pvt. Ltd. (Kasaav Dusting Powder): The advertisement’s claims, “KASAAV dusting powder – Create the beautiful moments in life, Kasaav gives the feeling of infancy in you”, “Best result in first use”, “Have the feeling of virginity” and “Kasaav powder is prepared by precious ayurvedic herbal mixture which helps to prevent the problem of loosening of vagina by making muscles tight and gives liveliest young feel to woman.  Kasaav powder is 15 days course will prevent the old memories and gives new hope and praise” are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Dindayal Aushadhi Pvt. Ltd. (303 Capsules): The advertisement’s claim, “Use 303 at Night” and the visual in the advertisement, read in conjunction with the claims objected to imply that the product is meant for enhancement of sexual pleasure and is considered to be, prima facie, in violation of the D&C Act.

     

    1.    Dindayal Aushadhi Pvt. Ltd. (303 Capsules): The advertisement’s claim, “Today or Tomorrow enjoy every moment” and the visuals in the advertisement read in conjunction with the claim objected to imply that the product is meant for enhancement of sexual pleasure, is considered to be, prima facie, in violation of the D&C Act.

     

    1.    Jeevan Jyoti Group of Hosp. (Arpit Test Tube Baby Center): The advertisement’s claim, “Complete and successful treatment for childlessness”, is considered to be, prima facie, in violation of the DMR Act.

     

    1.    Dr. Kamlesh Tandon Hospital and Test Tube Baby Centre: The advertisement’s claims, “Good news for childless couple – Now becoming mother is very easy through test tube method” and “Majority of patients succeeded with this scheme and taking healthy children to their homes”, are considered to be, prima facie, in violation of the DMR Act.

     

    1.    Akashdeep Hospital: The advertisement’s claim, “Successful Treatment centre for Epilepsy, Stroke”,  is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Rohilkhand Medical College and Hospital: The advertisement’s claims, “Successful treatment of uterus, tumors & cancer”, “Infertility treatment” and “All types of female diseases treated”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

     

    1.    Rejuvenate Hair Transplant Centre: The advertisement’s claim, “Rejuvenate presents effective and instant treatment through cosmetic surgery for freezed white spots which is incurable with medicine”, is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Vijaya Diagnostic Centre: The advertisement’s claims, “Lose Weight & Never Regain” and “Resolves – Diabetes, Hypertension, Heart Disease, Arthritis, Infertility”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Shri Ram Hospital: The advertisement’s claims, “Riddance to following diseases by obesity surgery:  Diabetes, Heart problems/Blood pressure.” and the before and after weight loss visuals appear to be misleading and imply cure from obesity, and are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Chellaram Diabetes Institute (Chellaram Diabetes Hospital): The advertisement’s claim, “Diabetes with Obesity is Curable Now!” is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Mohans Medicity Hospital: The advertisement’s claims, “Rule Out Women Cancers – In just two hours” and “Ultimate destination, for cancer cure”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Guru Hospital: The advertisement’s claim, “Cancer Cure without side effect by HI END linear accelerator with advanced technology”, is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Columbia Asia Hospital (Nobesity Centre): The advertisement’s claim, “Nobesity Centre – The name of centre implies cure from Obesity”, is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Sneha Counseling Centre (Sneha Clinic & Counseling Centre): The advertisement’s claim, “We provide medicines for depression, autism 100% cure”, is considered to be, prima facie, in violation of the DMR Act.

     

    1.    Dr. Tembe Hospital: The advertisement’s claim, “Effective Treatment for white spots”, is considered to be, prima facie, in violation of the DMR Act and  the D&C Act.

     

    1.    Slim-N-Health: The advertisement’s claims, “Eliminate Obesity by reducing Fat permanently and helpful in keeping away related diseases (Health Problems like Diabetes, Heart Problems, Bones & joint pains, Gynaec Problems, Hypertension, etc)”, are considered to be, prima facie, in violation of the DMR Act and  the D&C Act.

     

    1.    Mane Medical Foundation: The advertisement’s claim, “Successful treatment on white spots and Psoriasis” and the visuals in the advertisement read in conjunction with the claims in the advertisement implies that they offer a cure for white spots and Psoriasis and are considered to be, prima facie, in violation of the DMR Act and  the D&C Act.

     

    1.    Nurture Health Care (Ayurex S): The advertisement’s claim, “Experience of vigour and youthfulness in veins for weakness due to premature ejaculation”, is considered to be, prima facie, in violation of the D&C Act.

     

    1.    Amrita homeopathy: The advertisement’s claims, “INFERTILITY? IVF FAILURE? Worry no more! Meet our Experts!” and “Now your dream of having a baby will be a reality soon”, are considered to be, prima facie, in violation of the DMR Act.

     

    1.    Dr Richas Unique Clinic: The advertisement’s claim, “Height Treatment/ Ladies Bust Enlargement, Reduction Firming”, is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Sugar Control Clinic: The advertisement claims, “Sugar control clinic” and “can control sugar when all other options fail”, is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Khushi Ayurveda Pvt. Ltd. (Khushi Ayurveda Range Of Products): The advertisement’s claims, “100% effective treatment for Piles without any operation pain” and “Ten days of this course gives freedom from chronic piles and the pile warts permanently”, are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Capital Pharmacy (Attari Tel): The advertisement’s claims, “Yunani Medicine with guarantee for Paralysis, Arthritis” and “ATTARI Hemorrhoids Syrup – During Haemorrhoids drinking 2-2 spoons in morning and evening will stop the blood in haemorrhoids. By continuously drinking for three months, Bleeding Haemorrhoids will be cured completely”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Dr Rajesh Upadhyay Ksharsutra Clinic: The advertisement’s claim, “1st time in Agra successful treatment of piles, fistula & fissure through foreign machine, new technique, cryotherapy and kshar sutra”, are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Homeo Trends: The advertisement’s claims, “Confidence Solution to Sex Problems: Premature ejaculation, Right Solution to Infertility problems in Women, Excellent medicines in Homeo for Infertility problem compared to other medical procedures”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Grovel Drugs & Chemicals Pvt. Ltd. (Amrutha Dia Churnam): The advertisement’s claims, “Controls Diabetes, For Diabetic suffers (sugar patients), GROVEL presents an Elixir medicine”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Chaturbhuj Pharmaceuticals (Japani Oil): The advertisement’s claims, “For mellowness in Married Life, Specially Famous and Effective for Manly Power, The feeling of energy, stamina and Power” and the visuals in the advertisement and packaging read in conjunction with the claims objected to imply that the product is meant for enhancement of sexual pleasure. These claims are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Chaturbhuj Pharmaceuticals (Right Sugar Tablet): The advertisement’s claims, “Yes, Diabetes (Sugar) control now possible” and “Right sugar tablet works as the name is”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Hair Mantras: The advertisement’s claim, “New medicine will give riddance from baldness,” is considered to be, prima facie, in violation of the D&C Act.

     

    1.     Ruchi Herbals Pvt. Ltd. (Long Dive Range of Products): The advertisement’s claim, “Tell your problem and get the solution” and the visuals in the advertisement, product packaging and the product name imply that the product is meant for enhancement of sexual pleasure. The advertisement is considered to be, prima facie, in violation of the D&C Act.

     

    1.    Ruchi Herbals Pvt. Ltd. (Long Dive Range of Products): The visuals in the advertisement, product packaging and the product name imply that the product is meant for enhancement of sexual pleasure. The advertisement is considered to be, prima facie, in violation of the D&C Act.

     

    1.    Classical Homoeopath (Dr Mitwar): The advertisement’s claim, “Permanent treatment of genetic and incurable diseases,” is considered to be, prima facie, in violation of the D&C Act.

     

    1.    Heart & Health Care: The advertisement’s claims, “For happy married life”, “Now it’s possible to get rid of diabetes from roots” and  “Take successful treatment of masculine weakness, premature ejaculation, lack of sperm, discharge, undeveloped organ,” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    B K Arogyam & Research Center: The advertisement’s claims, “Permanent treatment for Kidney and Urethral stones”, “Get freedom without operation by experienced ayurvedic doctors” and “Get treatment for Kidney tumour,  piles, Gonorrhea and all kind of female and male venereal diseases,” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Devarshi Ayurved & Biotech Pvt Ltd (Devarshi Ayurved Range of Products): The advertisement’s claim, “Diabicure Product name implies cure from diabetes” is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Muniraj Ayurved Ashram (Muniraj Arsh Hari): The advertisement’s claims, “Sure shot medicine to remove piles”, “Successful ayurvedic medicine for all diseases like Piles, anal warts, Gonorrhea, Dysentery, fistula, cough etc.” and the product name imply cure from piles, are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Raj Pharmacy: The advertisement’s claim, “Disappointed from everywhere. Guaranteed treatment from roots without surgery for Piles, Fistula, fissure, hydrocele,” is considered to be, prima facie, in violation of the D&C Act.

     

    1.    Technopharm (Horse Power Capsules): The advertisement’s claims, “For women and men”, “Lack of semen and absence of sperm in it” and “Lack of interest in sex, anaemic,” are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Mahaguni Ayurveda Pvt. Ltd. (Mahaguni Ayurveda Range of Products): The advertisement’s claims, “Remove physical weakness”, “Take pleasure of married life” and the visuals in the advertisment read in conjunction with the claims in the advertisement imply that the treatment is meant for enhancement of sexual pleasure, are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Juneja Clinic (Juneja Modern Clinic): The advertisement’s claims, “Sex problems – men disease, Take seven days course of strength, premature ejaculation, Masculine weakness, loose nerves, undeveloped organ, thinness, Sloppy and less sperm,” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Lord Dhanvantari Hospital: The advertisement’s claims, “Finish from root of arthritis and Joint pain” and “100% Ayurvedic treatment from root for arthritis – joint pain – Hip, Joint Pain, waist pain, cervical, spondylolysis without operation,” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.     Olefia Biopharma Ltd. (Votif Syrup): The advertisement’s claims, “Votif Syrup – For all Sex Related Problems”, “Lack of sex desire or no willingness”, “Less or weak sperm. – Inability to complete the action of fertility”, “Decrease in erectile (Stunted)”, “Swelling of veins and not strengthens”, “No development of nerves”, “Happening of Premature Ejaculation and wet dreams”, “Less or thin Semen”, “Votil – Herbal and Natural Extract Syrup”, “Long Life Results Ordinary person can also use it and can make his body healthy and his married life happier” The visuals in the Ad and packaging read in conjunction with the claims             in the advertisement imply that the product is meant for enhancement of sexual pleasure are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Janta Clinic: The advertisement’s claims, “Avoid operation, Remove piles from roots by one injection” and “Successful treatment of fistula patients through Kshar sutra therapy” are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Sanjivani Ayurved Ashram: The advertisement’s claims, “Sex problems – Keep your marital life happy. Lack of sex desire, Premature ejaculation, Reduced erectile, Low & weak sperm, Undeveloped organ, Lack of stimulation due to weakness in nerves of organ”, “Our Ayurvedic treatment helps to transform your loose, undeveloped & flat breast into beautiful & attractive and improves physical attraction” and the visual in the advertisement read in conjunction with the claim objected to implies that the product is meant for breast enhancement. Also, the visuals in the advertisement read in conjunction with the claims in the advertisement imply that the treatment is meant for enhancement of sexual pleasure. The advertisement is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Sablok Clinic: The advertisement’s claims, “Meet without hesitation for sex problems”,  “No need to hide your sex related problems, if you are doing like that your marital life can become distressful” and the visuals in the advertisement in conjunction with the claims in the advertisement imply that the treatment is meant for enhancement of sexual pleasure are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Shivansh Ayurveda (Shivansh Ayrveda Range of Products): The advertisement’s claims, “Adopt ayurveda to increase height” and “Solution to men & women’s height through ayurvedic medicines” are considered to be, prima facie, in violation of the DMR Act and D&C Act.

     

    1.    Sex Samadhan Clinic: The advertisement’s claims, “Sexual Diseases, why get disappointed?”, “Free Japanese Penis Increaser Tool”, “Successful treatment of weakness of penis due to childhood mistakes, undeveloped organ, weakness of nerves, small organ, sloppy organ, thinness, impotence, childlessness, premature ejaculation, nightfall & every veneral diseases” and the visuals in the advertisements read in conjunction with the claims in the advertisement imply that the treatment is meant for enhancement of sexual pleasure, and are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Jivak Ayurveda: The advertisement’s claims, “Treatment of cancer”, “Complete ayurvedic solution to breast cancer, brain cancer, throat cancer, liver cancer, gallbladder cancer, blood cancer, bone cancer etc.” and “Jivak ayurveda is ray of hope for those who are suffering from cancer. See the results yourself within 21 to 45 days after taking the treatment” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Pankajakasth uri Herbals (I) Ltd. (Pankaja Kasthuri Orthoherb): The advertisement’s claim, “Use regularly and say good bye to Arthritis” is considered to be, prima facie, in violation of the DMR Act.

     

    1.    Shree Hari Clinic: The advertisement’s claims, “Get healthy without operation! Kidney Stone, Piles, Tumor, Heart Diseases”, “Childness couples must meet!” and “Operation less treatment for male – female infertility, Irregular menstruation, polycystic ovary, weak uterus and closed tube” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    S B Ayurvedic Speciality Hospital: The advertisement’s claims, “Vajikarna Treatment: Excellent medicines available in Ayurvedam without side effects for sexual problems due to mental reasons like depression, pressure, Anxiety etc. Ayurvedic medicine are giving better results. In Ayurveda, good medicines are also available for mental problems. As told in Ayurveda, Vajikarna medicines are solving problems like sexual problems, infertility” and “Get rid of sexual problems, infertility by Ayurveda experts with proper idea through sex counselling, Ayurveda medicines” are considered to be, prima facie, in violation of the DMR Act and D&C Act.

     

    1.    S B Ayurvedic Speciality Hospital: The advertisement’s claims, “In ayurveda there are excellent medicines for sexual problems arising due to Diabetes, High Blood pressure, Neurological disorders. Vajikarna medicine are used to treat sexual problems and which in turn resolves infertility problems also. By using Ayurveda medicines four to six months, Sexual and Infertility problems can be resolved,” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Homeocare International: The advertisement’s claim, “Possible Prevention to ‘ASTHAMA’ with Constitutional Homeopathy” is considered to be, prima facie, in violation of the D&C Act.

     

    1.    Homeocare International: The advertisement’s claims, “Efficient solution to ‘Spondylitis’ in Homeocare International” and “making back bone strong, there by chance of completely curing spondylitis problem without retaining this disease” are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Homeocare International: The advertisement’s claims, “Our Advanced Specialty Treatments to Diabetes, Peripheral, Neuropathy, Sex Problems, Kidney Problems, Diabetic foot and Eye Problems,” are considered to be, prima facie, in violation of the DMR and the D&C Act.

     

    1.    Alfa Hospital (Alfa Wellness): The advertisement’s claims, “Solution to every serious diseases of obesity at Alfa wellness: High blood pressure, Diabetes Type, Hypothyroid, and PCOD” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Makewell Pharmaceuticals (Speed Height Capsules): The advertisement’s claims, “Even after being short, there is a difference in my growth” and “Helps in physical growth” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Jolly Pharma (Jolly Fat Go Range of Products): The product name implies cure for obesity. Hence, the advertisement is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Jagat Pharma (Isotine Ayurvedic Eye Drops): The advertisement’s claims, “Treatment of less mature Cataract without operation” and “Cure for incurable diseases like Retinitis, pigmentosa, colour blindness etc.” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Navchetana Kendra (Navchetana Kendra Products-Debisulin): The advertisement’s claims, “In Ayurveda have wonderful herbs to help to cures the diabetes without side effects. Navchetana Kendra Designed a formulation Debisulin for your diabetes problems” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.     Navchetana Kendra (Navchetana Kendra Products- Recall Capsule): The advertisement’s claims, “Recall Capsule- A completely ayurvedic and chemical free capsule, made of rare herbal extract. It not just treats mental disorder/ailments but also takes care of your mind and nerve systems its good bye to stress, overthinking, depression and negativity from your mind and want to have a healthy mental state-‘Recall Capsule’ will be helpful and useful to get rid of those problems” are considered to be, prima facie, in violation of the DMR Act.

     

    1.    Sks Ayurveda Impex Pvt. Ltd. (SKS Height Plus): The advertisement’s claim, “With the use of this medicine you will improve your height in just 90 days of usage” and the visual in the advertisement read in conjunction with the claim objected to implies that the product is meant for increasing height. This is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Cosmo Vedant Herbal India (Vedantak Vati): The advertisement’s claims, “Sure shot medicine for arthritis” and “Get rid of arthritis,” are considered to be, prima facie, in violation of the DMR Act.

     

    1.    Reva Health & Skin: The advertisement’s claim, “How to decrease the belly fat? Treatment process – In the process of decreasing fat….body’s central part such as obesity,” is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Vardhan Ayurveda Hospital: The advertisement’s claim, “Treatment with best results through proven methods – Spondylitis,” is considered to be, prima facie, in violation of the D&C Act.

     

    1.    Sanjeevani Welfare Foundation (Sanjeevani Foundation): The advertisement’s claim, “Successful treatment for, Asthma, diabetes, venereal diseases through ayurved,” is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Khodiyar Ayurvedic: The advertisement’s claims “Cure chronic Haemorrhoids, Piles, Fistula, Fissure without operation from the roots through herbs and ayurvedic medicine with moneyback guarantee” and “100% money back guarantee for giving child to childless couple,” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Testo Ultra: The advertisement’s claim, “Increase member to four to eight centimetres in two weeks” and the visual in the advertisement read in conjunction with the claim objected to imply that the product is meant for improvement in the size of sexual organ. The advertisement is considered to be prima facie, in violation of the D&C Act.

     

    1.    Perfect Point: The advertisement’s claim, “Now put your first step to get freedom from diseases like obesity, blood pressure, diabetes and heart diseases,” is considered to be prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Perfect Point: The advertisement’s claim, “Reduce Belly Fat. – And get Relief from problems like Obesity, Blood Pressure, Diabetes and heart diseases,” is considered to be prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Ambe Physio Hospital: The advertisement’s claim, “Successful treatment of following diseases – Cervical, Paralysis, and Arthritis,” is considered to be prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Hcg Regency Oncology Healthcare Private Limited: The advertisement’s claim, “Previous accurate diagnosis is essential for successful treatment of cancer,” is misleading by implication of cancer cure. The advertisement is considered to be prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Super Speciality Hospital: The advertisement’s claim, “Freedom from Obesity” and the before and after visuals in the advertisement read in conjunction with the claim objected to implies cure from obesity. This is considered to be prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Mithal Cancer Center Enterprise (Meerut Cancer Hospital): The advertisement’s claim, “Treatment of cancer is possible”, is considered to be prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Keya Fertility: The advertisement’s claim, “This Year over 300 of Our Patients Will Be Smiling Too. Trying to conceive? Convert hope into success”, is considered to be prima facie, in violation of the DMR Act.

     

    1.    Akshar Surgical Hospital: The advertisement’s claims, “Benefits of Obesity Surgery: Cures, Diabetes, Get rid of Heart Diseases”, is considered to be prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Saaol Heart Centre: The advertisement’s claim, “Freedom from Heart diseases without operation, without surgery, without bypass, without Angioplasty”, is considered to be prima facie, in violation of the DMR Act.

     

    1.    R K Hospital: The advertisement’s claim, “Complete treatment for infertility”, is considered to be prima facie, in violation of the DMR Act.

     

    1.    Bhola Hospital: The advertisement’s claim, “Freedom from stones without surgery”, is considered to be prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Vansh Clinic & Test Tube Baby center: The advertisement’s claim, “Successful treatment of childless couples through Scientific method”, is considered to be prima facie, in violation of the DMR Act.

     

    1.    Shree Laser Hair & Skin Hospital Private Limited: The advertisement’s claims, “Any Type of Complicated and non-curable diseases can be Cured- Like Leucoderma, up to Hepatitis ‘B’ and Cancer in Stage I & II”, are considered to be prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Medicover Fertility: The advertisement’s claim, “Childless couples’ dream to have a healthy baby can now be fulfilled”, is considered to be prima facie, in violation of the DMR Act.

    EDUCATION:

    The CCC found following claims in the advertisements by 21 different advertisers were not substantiated and, thus, violated ASCI Guidelines for Advertising of Educational Institutions. Hence complaints against these advertisements were UPHELD.

    1.        Patel Group of Institutions: The advertisement’s claim, “Awarded for Best infrastructure, Best Faculty, Best Results & Best Placements”, was not substantiated with details of the awards, parameters used for assessment and other similar institutes that it was compared against, references of the award received such as the year, source and category. Also the claim is misleading by exaggeration.

     

    1.        Frankfinn Aviation Services Pvt. Ltd. (Frankfinn Institute of Air Hostess Training): The advertisement’s claim, “The World’s No.1”, was not substantiated with authentic supporting proof, and is misleading by exaggeration. Also the claim, “World’s No.1 air hostess training institute”, was not substantiated with any verifiable comparative data versus other similar institutes in the same category or any third party validation or research, and is misleading by exaggeration. Further the claims, “Gold Award Winner – 2016 for ‘Best Higher Vocational Institute for Skill Development’ – Awarded ‘Best Air Hostess Training Institute Award’ every year from 2011 to 2016” and “Limca Book of Records certified Frankfinn for best cabin crew placements year after year”, were not substantiated with copy of the award certificates, details, references of the awards received such as the year, source and category.  Also, the claims are misleading by omission of disclaimers to qualify these claims.

     

    1.        Jupiter: The advertisement’s claim, “The Only Institute in Patna with Experts in Every Subject”, was not substantiated with any verifiable comparative data versus other similar institutes in the same category or any third party validation or research to prove this claim, and is misleading. Also the claim, “Get Upto 100% Scholarship”, was not substantiated with authentic supporting data such as evidence of 100% scholarships availed by any of their students. The claim is misleading by exaggeration and ambiguity regarding the total number of scholarships being offered.

     

    1.        NRI Academy (HYD) – NRI Academy: The advertisement’s claim, “Guarantee the Engineering, IIT, NIT, BITS PILANI, Medical seats”, was not substantiated with any verifiable supporting data, and is misleading by exaggeration.

     

    1.        Vision 40 Academy IIT: The advertisement’s claim, “Offer guaranteed seats for IIT-JEE and NEET”, was not substantiated with any verifiable supporting data, and is misleading by exaggeration.

    Complaints against advertisements of all educational institutes listed below mostly are UPHELD because of unsubstantiated claims that they ‘provide 100% placement/AND/OR they claim to be the No.1 in their respective fields’:

    Sona School Management, OSK IT Solutions (OSK Consultant), National Academy of Event Management & Development, Rural Research and Development Agency (Sri Annai Nursing College), Nehru College of Education and Charitable Trust (Nehru Group of Institutions), PV Media Ventures Private Limited (Roc Talent Junction), Hindustan Air Academy, NILAYA’S ICATS Institute of Commerce, An IGP Pvt. Ltd. (CA Ashish Kalra’s IGP e-learning Classes), Swapnil Patni’s Classes, IAM Business School, Mentors Eduserv, Indo German Tool Room-Gv, Excellence Knowledge City-VC, S K Educations Pvt. Ltd. and Sri Nanesh Vikas Trust Samta.

     

    FOOD & BEVERAGES:

    1.        A V Thomas & Co. Ltd. (AVT Premium Tea and AVT Premium Select Tea): The advertisement’s claim, “Strongest Tea consistently” is a superlative claim which was not substantiated with supporting comparative data versus other tea brands. Also, the claim is misleading by exaggeration and implication that other tea brands are inferior to the advertised product.

     

    1.        Apurva Organics Ltd. (Chamong Green Tea): The advertisement’s claims, “100% Organic” and “IMO certified” were not substantiated and are misleading by exaggeration. 

     

    1.        Mahesh Edible Oil Industries Ltd. (Saloni Mustard Oil): The advertisement’s claims, “Vitamin A – Helps to improve eyesight”, “Vitamin D – Helps in making bone stronger” and “Vitamin E – Helps to strengthen immunity”, were not substantiated with quantitative evidence of the presence of Vitamins A, D and E in the product.

     

    1.        Sri Family Biznet (P) Ltd. (Udupi Ruchi products): The advertisement claims, “Rava Idli: The micro nutrients in this prevents insulin loss. Reduces bad fat and regular eating of this keeps you young”, “Raagi Idli: Helps fat loss. Strengthens bones, cures kidney stones and also suggested for diabetes patients”, “Oats Idli: Reduces fat storage in the body. Reduces heart diseases. Builds immunity and reduces breast cancer in females”, were inadequately substantiated and are misleading by implication. 

     

    1.        Sri Family Biznet (P) Ltd. (Udupi Ruchi Products): The advertisement’s claims, “Ragi Dosa: Cures kidney stones. Maintains haemoglobin level in the blood, maintains weight, and maintains blood pressure”, “Rice Dosa: Good for heart”, “Rava Dosa:  Helps in building the immunity power. Good for pregnant ladies and those who are in their menstrual periods to compensate for the blood loss, Controls insulin secretion, Maintains blood pressure level” and “Multi grain dosa: Improves immunity, controls diabetes, controls oestrogen secretion in women”, were inadequately substantiated and are misleading by exaggeration.

     

    1.        Keshav Industries Pvt. Ltd. (Keshav Edible Oils Range): The advertisement’s claim, “Health Booster” is misleading by implication of enhancement of health as the advertisement also states “Use Kash and be worry-free”. Further the claim, “Keeps food ingredients fresh for long” was not substantiated with any technical data, and is misleading by implication. 

     

    1.        Heinz India Pvt. Ltd. (Complan): The advertisement’s claims, “Only Complan gives three times more (3X Zyada)”, “As every glass of Complan has 34 vital nutrients, two glass of milk protein (2X Milk Protein) because of which children grow/develop the most”, were not substantiated and are misleading by ambiguity and implication. 

     

    OTHERS:

    1.        Bharti Airtel Ltd. (Free Data for 12 months): The advertisement’s claim, “Free data for 12 months, worth Rs. 9000. Switch to Airtel 4G”, is misleading by ambiguity. It was noted that the price currently being used by Airtel for 3 GB data is Rs. 450/-.  The prevalent price of ‘free data’ under an actual offer for 12 months is much lower than the price point of Rs. 9000.  The said unlimited data packs are not entirely free but they are subject to specific tariff packs for which the customer is required to pay. Furthermore, the data pack is valid for only 28 days and the 12 re-charges of 28 days each do not add up to 12 months. 

     

    1.        Bharti Airtel Ltd. (Free Unlimited local + STD calls): In view of the cap of 1200 minutes / week as per advertiser’s fair usage policy, the claim, “Free Unlimited Local + STD calls” is misleading and contravened Chapter I.4 of the ASCI Code as well as Clause 1 of ASCI Guidelines for Disclaimers (“A disclaimer can expand or clarify a claim, make qualifications, or resolve ambiguities, to explain the claim in further details, but should not contradict the material claim made or contradict the main message conveyed by the advertiser or change the dictionary meaning of the words used in the claim as received or perceived by a consumer.”).

     

    1.        Bharti Airtel Ltd.: The advertisement’s claim, “India’s fastest network” after referring to the terms and conditions (https://www.airtel.in/fastestnetwork/download/termsandconditionsfastestnetworkookla.pdf) and noting the specific clauses, was considered to be in contravention of the ASCI Guidelines on Disclaimers, Clause I, because it renders the principal claim of the advertisement being the “Fastest Network” null and void. The specific clauses are – “…..4. Airtel has no liability whatsoever in respect of any claims or disputes and any resulting damages or losses, whether direct or indirect, relating to the customers’ use of the network. 5. Airtel makes no warranties or representations whatsoever in respect of the mobile services including as to its fitness for any particular purpose, merchantability, quality, availability, disruption or error free operation. Please note that the statements in these terms and conditions do not constitute any general representation from Airtel regarding Airtel’s services or its availability. Airtel’s network is available on an ‘as is where is available’ basis and Airtel makes no representation, guarantee or warranty regarding the availability, fitness for any specified purpose or error free operation of the network. Network availability may be affected due to various reasons including force majeure, acts of god, inclement weather, topographical/ geographic/ demographic factors, maintenance work, availability of interconnection with other networks, etc.” Furthermore, the advertisement does not state in the claim itself that the speed results pertain to only a specific period (ie. “The period taken to conduct speed test is from Q3-Q4 2016”). It was also noted that the claim by the advertiser is not specific to 4G technology whereas the advertisement has visuals with reference to 4G. The speed comparison visual also has a reference to 4G in the notification bar and shows poor signal strength for the other service provider. This representation was considered to be misleading by ambiguity and implication. Further it was concluded that the claim was not adequately substantiated and the basis of comparison has been so chosen as to bestow and artificial advantage to the advertiser. Additionally, for the claim, “Officially the fastest network” it was also considered the term “Officially” to be misleading as this test is not based on any government organization or recognized authority such as TRAI in this category and hence, exploits consumers’ lack of knowledge.

     

    1.        Jewel Souk Marketplace Limited (Sangini Diamond Jewellery): The advertisement’s claim, “India’s Most trusted Jewellery Brand”, was not substantiated with any market research data or any comparative data versus other similar brands in the same category. The claim is not qualified to mention the source and date of research and criteria for assessment for the claim made. Also, the claim is misleading by ambiguity and omission. 

     

    1.        LG Electronics India Pvt. Ltd. (LG Air Conditioner): The advertisement’s claims,   “30 percent faster cooling”, “66 percent extra energy saving compared to other AC”, were not substantiated and are misleading by exaggeration and implication that other air conditioners are inferior to the advertised product. Also the claim, “keep mosquito away”, was not substantiated with supporting evidence and is misleading by exaggeration. Further the disclaimers in the advertisement are not legible, are not in the same language as the audio of the advertisement (Hindi), and the hold duration of the disclaimers is not in compliance with the ASCI Guidelines.

     

    1.         Relaxo Footwears Ltd. (Relaxo Sparx Shoes): The advertisement’s claim “India’s most trusted brand in footwear category – Brand Trust Report 2016” was likely to be understood by consumers as a comparison about the advertiser’s product with their competitor brands. It was concluded that in the absence of survey methodology, questionnaires used, names of other similar footwear that were part of the survey and their outcome, the claim was inadequately substantiated and is misleading.

     

    1.        Jasper Infotech Pvt. Ltd. (Snapdeal – Amway Persona 100% Pure Coconut Oil): The advertisement claiming the MRP of the product Amway Persona, 100% pure 400 grams as Rs.619, and offering at the discounted price of Rs.239 (61% off), is false, distorts facts and is misleading the consumers as to actual product and discount being offered, as the actual MRP of the product 500 ml (457.5 g) being Rs.190 at which it is sold.

     

    1.        Crusaders Technologies (Crusaders Air Purifier) Pvt. Ltd.: The advertisement’s claim, “India’s No.1 Air Purifier”, was not substantiated with any verifiable comparative data versus other air purifiers in the same category or any third party validation or research to prove this claim, and is misleading by exaggeration.

     

    1.    Asian Paints Ltd. (Smart Care Solutions): The advertisement’s claim, “Warranty wala waterproofing”, is misleading by omission. The advertisement does not indicate or provide reference to criteria under which the claim holds / does not hold.
  • ASCI introduces ‘Independent Review Process’, appoints Justice Mudgal as chairman

    MUMBAI: The Advertising Standards Council of India (ASCI) has introduced an ‘Independent Review Process’. This procedure facilitates an independent mechanism to review the recommendations made by Consumer Complaints Council (CCC) if either the advertiser or the complainant is dissatisfied with such recommendations.

    The new Independent Review Process will have a chairman, who will be a retired Judge of the Supreme Court/High Court, assisted by the secretary general/chief complaints officer, along with the chairman or co-chairman who was involved in the CCC recommendation and a technical expert, where necessary. Currently, Justice Mukul Mudgal (Retd. chief justice of Punjab and Haryana, High Court) has been appointed by the self-regulatory organisation as the chairman for all Independent Review Process cases henceforth.

    ASCI has been rapidly progressing on various initiatives for upholding self-regulation in advertising, safeguarding consumers’ interest and partnering with various government bodies in restraining misleading advertisements. This has led to a substantial increase in ASCI’s responsibilities and work load. In this background, ASCI appoints Dr. CBS Venkataramana, IAS (Retd.), as the chief complaints officer (CCO), who will play a vital role in driving efficient complaint redressal and 360 degree stakeholder interactions.

    Serving as an Indian Administrative Service (IAS) officer for about 33 years, Dr. Venkataramana has undertaken several important assignments at the State Govt. and Central Govt. level. In his role as the CCO, Dr. Venkataramana will be responsible for managing complaint lodging, investigation, redressal and follow up processes for effective compliance of ASCI codes.

    Commenting on these initiatives, ASCI’s chairman Srinivasan K. Swamy said, “ASCI is constantly evolving and seeking effective measures to enable self-regulation in advertising and compliance to ASCI codes. The inclusion of the Independent Review Process mechanism creates transparency for both advertiser and complainant in further facilitating fair judgement of complaints. Further, the appointment of Dr. Venkataramana will go a long way in ensuring speedier and more effective complaint redressal process.”

    DETAILS: The Independent Review Process is applicable where the CCC recommendations are made after considering the response received from the Advertiser and on fulfilling the following conditions by the party seeking review:

    A written application, in the prescribed form, (available on the ASCI website) has to be submitted within 10 business days of the receipt of CCC recommendations.

    The application is accompanied by a non-refundable prescribed Fee plus applicable taxes.

    The Parties will be at liberty to provide additional information/material not submitted earlier together with the application as per (a) above. Additional information/material submitted by the complainant seeking a review will be sent to the advertiser who shall send his response to the ASCI secretariat in five business days from the date of receipt of such additional information/material.

    The advertiser seeking review confirms suspension of the offending advertisement, pending the Independent Review Process recommendations. By submitting the Independent Review Process application, it is understood that the advertiser shall accept and comply with the recommendations made by the Chairman of the Independent Review Process.

    The Independent Review Process meeting will be convened once in a Fortnight/Month. Both the complainant and the advertiser will be intimated as to the date, time and venue of the meeting at least 5 business days prior to the date of the meeting.

    Proceedings under the Independent Review Process are not adversarial or adjudicatory in nature and hence parties may be represented in the meeting by their company officials only.

    The Chairman of the Independent Review Process, after hearing both parties, will give his/her recommendations within two business days thereafter. In case, additional information or clarification is required from either party or the technical expert, the Chairman may, as per his/her discretion, continue the hearing on another convenient date.

    In the event either of the parties do not wish a personal hearing, the Chairman of the Independent Review Process may complete the review based on the additional information/material submitted and his/her findings would be conveyed over email to both the parties within a period of 2 business days.

    Independent Review Process shall not be applicable in case of ex-parte CCC recommendations. However, Re-examination of such recommendations will be undertaken by the CCC on payment of prescribed fee plus applicable taxes (which at the discretion of ASCI maybe reduced/ waived off in deserving cases) and adhering to the conditions laid down in clause (a) (d) & (e) above.

  • ASCI bags gold award for mobile app ‘ASCIonline’

    MUMBAI: The Advertising Standards Council of India (ASCI) has bagged the gold award for their Mobile App “ASCIonline” to receive consumer complaints against false advertisement at the Global EASA Best Practice Awards 2016.

    The Indian self-regulatory advertising watch-dog was awarded the prestigious prize at Athens on 8 May 2017 for launching the best initiative globally providing “Prompt and efficient complaint handling at no cost to the consumer”.

    The Consumer Complaint Mobile App – ASCIonline – was launched in June 2015 to provide easy and convenient access for lodging complaints, increasing ASCI’s reach across India.

    With a catchy slogan ‘Snap It and App It’, the App lets consumers’ flag complaints against offensive/misleading/vulgar advertisements. For every complaint, they get real-time auto updates within the App every time the status of the complaint is changed with regard to the progress of the complaint.

    Keeping the design and interface clean, uncomplicated, and user-friendly, ASCI has ensured to rightly “M(obile)–Power” consumers providing the utility to voice against misleading advertisements.

    This Free App which is available on android and iOS platforms continues to contribute upto 10% in the total number of complaints received even today.

    ASCI chairman Srinivasan K. Swamy said, “We are delighted to receive this esteemed honour from EASA for recognizing our efforts towards strengthening ASCI’s role in self-regulation in the country. Continuing with the mission to protect consumers’ interest, ASCI embraced technology to connect with the consumers and curb misleading advertisements. This pathbreaking initiative has spurred expand ASCI’s reach significantly across many smaller cities and towns. The App was also referred to by Government Departments in India and appreciated for the pro-activeness of ASCI. After three successive wins in the past, acquiring another Gold has further provided cognisance for the SRO on an International platform as well.”

    ASCI is now a part of the Executive Committee of the International Council on Advertising Self-Regulation (ICAS), which unites global Self-Regulatory Organisations (SROs) and international Industry Associations to form a powerful body that will facilitate the establishment of new SROs in emerging markets, help empower them and provide a platform to discuss and work on solutions regarding the global challenges faced for self-regulation in advertising.

  • Healthcare products lead in ASCI norms breach, 143 complaints upheld

    MUMBAI: Healthcare products, followed by education category, led in breaching various norms set by Advertising Standards Council of India (ASCI) on advertisements and getting  hauled up for the same in the month of January this year, according to an official statement from the advertising self-regulatory body.

    ASCI yesterday noted that its Consumer Complaints Council (CCC) upheld complaints against 143 out of 191 advertisements. Out of 143 advertisements against which complaints were upheld, 102 belonged to the healthcare category, 20 to the education category, followed by seven in personal care category, six in the food & beverages category and eight ads from other categories.

    Some of the big companies and products pulled up by ASCI include Apple, Amul, Qi Lifecare Pvt. Ltd, Nivea India, HUL, Standard Chartered Bank and Coca-Cola India.

    HEALTHCARE

    The CCC found the following claims of 102 advertisements in healthcare products or services to be either misleading or false or not adequately/scientifically substantiated and violating ASCI’s norms. Some of the healthcare products or services advertisements also contravened provisions of the Drug & Magic Remedies Act and Chapter 1.1 and III.4 of the ASCI code.

    Complaints against the following advertisements, amongst others, were upheld:

    1. Proyurveda Lifescience Pvt. Ltd. (Max ARTHO Capsules, Oil and Gel): The advertisement’s claims that it “helps in protecting joint cartilage by reducing degeneration” and “helps in treating the root cause of joint pain” were inadequately substantiated and are misleading by implication.

    2. Nurture Health Care (Medora Capsules): The advertisement’s claim (in Marathi) as translated into English — “Medora capsules deliver weight reduction without any lifestyle changes” — was not substantiated with evidence of product efficacy and is misleading by exaggeration. 

    3. Qi Lifecare Pvt. Ltd. (Qi Spine Clinic): The advertisement’s claim, “new treatment approach helps 50-year-old achieve complete recovery from 12 years of chronic back pain”, was inadequately substantiated. It was considered that the testimonials did not constitute reliable objective evidence and did not entitle the advertiser to make very broad claims made in the advertisement regarding surgery-free recovery.

    Consumers were likely to understand that the testimonial was genuine representation of complete recovery from chronic back pain by the advertised treatment alone and was representative of the results that could be generally achieved by taking the treatment. Also, since the physiotherapy treatment approach is well established, calling it “new” was considered to be misleading. Further, the claim, “India’s first back pain specialist”, was not substantiated with comparative data versus other similar clinics providing similar treatment to prove this claim.  Also, the claims are misleading by exaggeration.

    4. Shree Maruti Herbal (Stay On Power Capsules): The advertisement’s claim — “clinically 99.99 per cent efficacy proven power capsules” — was not substantiated with clinical evidence of product efficacy.  Also, the claim when read in conjunction with the text in the body copy of the advertisement and product visual is misleading by implication that the product, which as per pack declaration is “herbal supplement for men”, is for improvement in their capacity for sexual pleasure.

    It was noted that this medical product is being presented as an “amazing gift”, which people could exchange for Diwali among friends, and considered to be misleading by ambiguity and a manifestation for a disregard for safety while consumption of the product could encourage negligence. It was further concluded that the advertisement gives a false impression regarding the true character of the medicine and is in breach of the law as it violated the Drugs & Magic Remedies Act (DMR Act).

    EDUCATION:

    The CCC found claims in the advertisements by 20 different advertisers were not substantiated and, thus, violated ASCI guidelines for advertising of educational institutions. Hence, complaints against these advertisements were upheld. Some of the upheld cases are the following:

    1. Vidyamandir Classes: The advertisement’s claim — “cash reward worth (Rs) 2 crore (Rs 20 million)” — was not substantiated with supporting evidence of students who have received cash worth Rs. 2 crore.  Also, the claim (“scholarship up to 100 per cent”) was not substantiated with authentic supporting data such as evidence of 100 per cent scholarships availed by students. The claims were found to be misleading by exaggeration.

     2. Cadd Centre India Private Ltd. (Cadd Centre-Ce): The advertisement’s claims (“First Time Ever In India! 1000 Jobs In 100 Days For Cadd Quest Participants” and “Job Guarantee For 1000 Students”) were not substantiated with verifiable support data such as detailed list of students who have been placed through its institute, contact details of students for independent verification, enrolment forms and appointment letters received by the students, nor any independent audit or verification certificate. The claims are likely to mislead students into believing that the institute is providing permanent jobs.

    PERSONAL CARE

    1. Nivea India P. Ltd. (Nivea Protect & Care Deodorant): The print advertisement has visual of Nivea crème super-imposed on the deodorant can image and claims were considered to be misleading by ambiguity and implication that several other major ingredients (and not only fragrance) of Nivea Crème were added to the deodorant product. The front of the pack claim (“with Nivea Crème ingredients”) accompanied by a visual of cream, and back of pack claim of “with precious Nivea Crème ingredients” is likely to mislead the consumers that Nivea Protect & Care Deodorant has several major skincare ingredients of Nivea Crème. The pre-dominant common element of both the products is the Nivea fragrance. These claims are misleading by ambiguity.

    2. Richfeel Health & Beauty Pvt. Ltd.: The advertisement showcases pictures of results of both pre and post treatment. It was noted that the advertiser did not provide its response specific to the claims/visuals objected to, nor did it provide photographic evidence to prove that the pictures shown in the advertisement (pre and post treatment) are demonstrating the real benefit achieved through the treatment. It was concluded that the efficacy being depicted via images of before and after the treatment are false and misleading by gross exaggeration. Without this evidence, addition of any disclaimers was not considered acceptable.

    3. Hindustan Unilever Limited (Rin Antibac): The advertisement’s claim (“Presenting new Rin Antibac with Ayurvedic extracts removes germs”), accompanied by visuals implying sterile clothes, was not substantiated and is misleading by implication and exaggeration as the advertised product does not have the property to provide germ protection in wear conditions. As clothes will be exposed to different environments, they would be contaminated and would carry germs. Both the claims, that is germ inhibition/sterile clothing in wear conditions and provided only by the advertised product (i.e. other detergent not providing similar benefit), were not substantiated.

    FOOD & BEVERAGES

    1. S.V.Fruit (Go Green Frozen Fruits): It was concluded that while the advertised product may be carbide free, claiming it to “protect from cancer” is misleading by exaggeration.

    2. Gujarat Co-Operative Milk Marketing Federation Ltd. (Amul Butter): The advertisement refers to butter being a rich source of Vitamin A and further states that “eat milk with every meal and live every day, worry-free”. It was considered the latter part of the statement was misleading by implication and encouraging excessive consumption of butter, which may not be advisable from a health point of view.

    3. Coca-Cola India Pvt. Ltd. (Thums Up): The advertisement showcases a rider performing a wheelie on normal streets and traffic conditions amongst a few people.  This is contradictory to the disclaimer made in the advertisement — “the actions are for representational purposes alone and must not be copied by viewers”.  It was concluded that though the overall advertisement is not objectionable, regardless of the disclaimer, the specific visual showing the stunt performed by the rider (wheelie) in normal traffic and/or in presence of bystanders and public encourages dangerous practices and encourages a disregard for safety and negligence.  

    OTHERS

    1. Standard Chartered Bank (Standard Chartered credit card): The advertisement claims that “get up to 10 per cent extra cash back on all spends with your Standard Chartered credit card”. It was considered to be false and misleading by ambiguity as the cash back being offered is limited to Rs.10, 000.

    2. Apple India Private Limited (Apple): The advertisement’s text states that “the amazing iPhone 7 is here”, but shows an image of iPhone 7 Plus variant, which is misleading by ambiguity and implication.  While the advertiser may have a logo/trademark with “iPhone7”, by omission of any reference to the word “series” in the advertisement text and in absence of any visual of iPhone 7 variant, it was concluded that the advertisement is likely to mislead consumers about the product advertised and its corresponding features.

    3. Opera Software Asa (Opera Mini): The advertisement’s claim — “saves data cost up to 90 per cent while browsing” — was not substantiated with supporting data and is misleading by exaggeration.

     ASCI is a self-regulatory organization for the advertising industry to promote, maintain, monitor and uphold fair, sound, ethical and healthy principles and practices of advertising for the protection of interest of consumers and the general public. Established in 1985, ASCI’s role has been acclaimed by various government agencies like the Department of Consumer Affairs (DoCA), Food Safety and Standards Authority of India (FSSAI) and Ministry of AYUSH.

    ASCI and its Consumer Complaints Council (CCC) deal with complaints received from consumers and industry against advertisements that are considered as false, misleading, indecent, illegal, leading to unsafe practices, or unfair to competition and in contravention of the ASCI code for self-regulation in advertising.

    The full list of companies/adverts hauled up by ASCI for breach of norms could be found here.

  • Celebrities must do due diligence before endorsing products: ASCI

    MUMBAI: Celebrities have been deployed by marketers to add credibility to their brand offering. These celebrities however have a huge responsibility to ensure that the products they endorse or feature in, are true to the claims made in those advertising messages.

    Advertising Standards Council of India (ASCI) has developed a set of guidelines to protect consumers’ interest while encouraging celebrities and advertisers to refrain from endorsing misleading advertisements. At a time when the Consumer Affairs Ministry is intending to review the Consumer Protection Act and may have a provision to deal with misleading advertisements featuring celebrities, these guidelines by ASCI could serve as a good reference for advertisers.

    The Advertising Standards Council of India is a self-regulatory organisation for the advertising industry to promote, maintain, monitor and uphold fair, sound, ethical and healthy principles and practices of advertising for the protection of interest of consumers and the public.

    The following guidelines would help while creating advertisements featuring celebrities or involving celebrity endorsements:

    * Celebrities, for the purpose of this guideline, are those people who are from the field of Entertainment and Sports and would also include other well-known personalities like Doctors, Authors, Activists, Educationists, etc. who get compensated for appearing in advertising.

    * All advertisements featuring Celebrities should ensure that it does not violate any of the ASCI code in letter and spirit. Celebrities are expected to have adequate knowledge of these Codes and it is the duty of the Advertiser and the Agency to make sure that the Celebrity they wish to engage with is made aware of them.

    * Testimonials, endorsements or representations of opinions or preference of Celebrities must reflect genuine, reasonably current opinion of the individual(s) making such representations, and must be based upon adequate information about or experience with the product or service being advertised.

    * Celebrity should do due diligence to ensure that all description, claims and comparisons made in the advertisements they appear in or endorse are capable of being objectively ascertained and capable of substantiation and should not mislead or appear deceptive.

    * Celebrities should not participate in any advertisement of a product or treatment or remedy that is prohibited for advertising under:

    I. The Drugs & Magic Remedies (Objectionable Advertisements) Act 1954 as updated from time to time ( Link for preliminary guidance http://lawmin.nic.in/ld/PACT/1954/A1954-21.pdf and http://drugs.kar.nic.in/node/136.html) or

    II. The Drugs & Cosmetic Act 1940 and Rules 1945: (Schedule J) as updated from time to time (Link for preliminary guidance http://www.cdsco.nic.in/writereaddata/2016Drugs and Cosmetics Act 1940 & Rules
    1945.pdf and http://www.indianhealthservices.in/schedules/Schedule_J.pdf ) or

    III. A product which by law requires a health warning “…..is injurious to health” on its packaging or advertisement.

    * If the Celebrity either directly or through the concerned Advertiser/Agency chooses to seek Advertising Advice from ASCI on whether the advertisement potentially violates any provisions of the ASCI code or not and if the Advertisement is developed fully following the Advertising Advice provided by the ASCI, then the Celebrity would be considered as having completed due diligence. However, ASCI’s Advertising Advice will not be construed as pre-clearance of the Advertisement.

    Commenting on the new guidelines, ASCI chairman Srinivasan K. Swamy said, “Celebrities have a strong influence on consumers and are guided by the choices they make or endorse. It’s important that both celebrities and advertisers are cognizant of the impact and power of advertising and therefore make responsible claims to promote products or services. It is in the interest of advertisers / ad agencies as well as celebrities to be aware of these guidelines and be sensitized to this issue to avoid violations.”

    The ASCI’s guidelines help in ensuring that claims made in advertising are not misleading, false or go unsubstantiated. Advertisers following these guidelines will protect the interests of the consumers, especially for products or services, which can cause serious financial loss or physical harm.

  • Review ‘fastest network’ ad order, Airtel appeals to ASCI

    MUMBAI: Airtel has filed an application before the watchdog The Advertising Standards Council of India (ASCI) for the review of decision with additional material to support its advertisement campaign. ASCI had concluded the ad claiming Airtel to be “officially” fastest network as misleading and asked the company to withdraw or modify the commercial by 11 April.

    Telecom major Bharti Airtel filed the appeal seeking review of ASCI’s decision that sought modification or withdrawal of the company’s ‘fastest network’ campaign. Airtel had come out with a television commercial (TVC) claiming to be India’s fastest network based on Ookla’s finding. Its new competitor Jio had contested the claim and moved the ASCI against the commercial.

    ASCI’s Fast Track Complaints Committee (FTCC) upheld Jio’s complaint on 29 March that Bharti Airtel’s commercial depicting it as having the fastest telecom network in the country is misleading. The committee of ASCI ruled that the “TVC and website advertisement contravened” ASCI rules. Bharti Airtel had said it will file an appeal against the order.

    Upholding the complaint filed by rival Reliance Jio Infocom, ASCI said the Airtel TV commercial (TVC) was “misleading” and “contravened Chapters” of its Code as well as guidelines on disclaimers clauses.

    Ookla had also responded to ASCI decision saying that it fully stands behind the reliability and accuracy of the methodology used to designate Airtel as ‘India’s Fastest Mobile Network’.

    Also Read:

    Airtel hits back at Reliance Jio, Ookla stands by its findings

    Airtel does not agree with ASCI’s ‘conclusion’ on misleading ad

  • Govt. again rules out IMC reconstitution, says checks adequate

    NEW DELHI: The Government has once again ruled out any reconstitution of the Inter-Ministerial Committee which examines complaints against television channels.

    The minister of state for information and broadcasting Rajyavardhan Rathore told the Parliament this week that the IMC “already includes representatives from various Ministries concerned and the industry.”

    He also said that the existing provisions contained in the Programme & Advertising Codes and the existing mechanism are considered adequate to regulate content of private satellite TV channels. “No shortcomings have been found in the functioning of the IMC”, he added.

    Similar questions have been asked in this and previous sessions and the government has repeatedly said there is no proposal to reconstitute IMC.

    Content telecast on private satellite TV channels and transmitted/re-transmitted through the Cable TV network is regulated in terms of the Programme and Advertising Codes prescribed under the Cable Television Networks (Regulation) Act 1995 and Cable Television Network Rules 1994 framed thereunder.

    The Act does not provide for pre-censorship of any programme or advertisement telecast on such TV channels. However, all programmes and advertisements are required to be in conformity with the said Programme and Advertising Codes.

    The IMC functions under the Chairmanship of Additional Secretary (I&B) and comprises officers drawn from Ministries of Home Affairs, Defence, External Affairs, Law, Women and Child Development, Health & Family Welfare, Consumer Affairs, Information & Broadcasting and a representative from the industry in Advertising Standards Council of India (ASCI) to take cognizance suo-motu or look into specific complaints regarding violation of the Programme and Advertising Codes.

    He said the IMC functions in a ‘recommendatory’ capacity. The final decision regarding penalties and its quantum is taken by the Ministry on the basis of the IMC recommendations.

  • Goafest 2017: Change is possible when one takes risks, says Patanjali’s Balkrishna

    GOA: Who would have thought that in the advertising and marketing world of suited-booted  and/or casual linen chic people, a simple robe clad guy would turn out to be dude? Well, who would have wagered a few years back that Patanjali would be a starred speaker at India’s annual advertising, media and marketing convention and have a houseful of corporate execs hanging on to every word, some of which were spoken in chaste Hindi? Desh badal raha hai (or, the country is changing), after all, in ways that the countrymen and women are still grappling to come to terms with.

    “The nation is ours, the children are ours, life is ours. We must take care of it ourselves. Always remember, for the world, India is just a market place (but) for us it’s our home. Change is possible only when one is willing to take risks,” Patanjali Ayurveda CEO Acharya Balkrishna said with a straight face, but with a confidence that comes from the realisation that some of the top global FMCG companies were feeling the heat of Patanjali’s unrelenting advertising and marketing blitz.

    The oozing confidence found other outlets too. Without giving a second thought, Balkrishna took on a competitor. “ Patanjali set up a factory in Tejpur in Uttar Pradesh where Dabur too was setting up its factory. In 120 days, Patanjali built up the factory with same workers who were (earlier) working for Dabur,” said the Nepal-born Balkrishna, regarded as the No. 2 in the Patanjali group hierarchy, just next to its yoga guru founder-turned-entrepreneur Baba Ramdev.

    In the FMCG space, some of the Patanjali Ayurveda products that have eaten into the market share of established global and Indian companies include Dant Kanti (toothpaste), atta or flour noodles, multi-grain and plain flour for rotis or Indian bread and Kesh Kanti (hair oil), apart from other categories where Patanjali products are giving a tough competition to the likes of Dabur, ITC, P&G Colgate-Palmolive and Unilever India.

    “Patanjali Ayurved has turned out to be the most disruptive force in the Indian FMCG market…it witnessed a whopping annual growth of 146 per cent in fiscal year 2016 grossing a turnover of US$769 million, whereas its peers, including ITC, Dabur, Hindustan Unilever, Colgate–Palmolive and Procter & Gamble struggled to get a growth much less than double digit,” an Assocham-TechSci research report has stated.

    So, what’s the secret of Patanjali in a country that had been dominated by established FMCG players, especially as its founder Ramdev’s antecedents have been questioned at various times?

    Pointing out that the Haridwar-based company doesn’t  follow any marketing strategy, depending more on “product quality” to attract consumers, Balkrishna played with a straight bat on the opening day of Goafest 2017 yesterday: “Treat your customers as your family members and everything (else) will fall into place. We want to change the impression that made-in-India products are not of good quality.”

    If some of these home grown homilies were not enough to rub it in to much-experienced global players, Balkrishna told the audience at Goafest that “duniya ke liye Hindustan ek bazaar ho sakta hai, humare liye Hindustan humara ghar hai” (for the world, India may be a bazaar, but, for us, it’s our home) and change was possible only when one was willing to take risks. Hmm! Hang on, there was more for those willing to listen and the numbers were astounding.

    “Toothpaste is meant to clean teeth, but nowadays ads say you can get a girlfriend using the right (tooth) paste,” Balkrishna said with his tongue firmly in cheek, adding, “humare liye humari maryada sabse badhkar hai, sales na ho toh bhi thik hai” (for us, self-respect and respect for our culture is paramount, and not sales of products).

    However, Balkrishna did not wander into controversial areas where ASCI, in the past, has hauled up Patanjali for misleading advertising or the court cases against it or filed by the company itself relating to product advertsing and claims.

    A fitting tribute to Patanjali’s efforts also came from a competitor. “’Patanjali has shown us marketing methods we never knew,” graciously admitted ITC’s divisional CEO – foods business Hemant Malik, while speaking at another time of the day.

    As a parting shot to urban India — many of whose representatives were at Goa — Patanjali’s Balkrsihna told the gathering that Indians “should eat according to the six seasons because our body changes in every season” as do its requirements. “The problem in India is that people in rural (areas) are healthy, but people in metros have nutritional deficiency,” Balkrishna  explained.

    Other speakers for the opening day included Mobikwik co-founder and director Upasana Taku and ITC’s Malik.

    According to Malik, “Communication is the not the only pillar for branding”  as there are brands such as Facebook, Amazon and Google that have changed the world. “It’s all about the product differentiation. We are the only carbon-positive company in the world,” Malik spoke about the shift from hierarchical collectivist culture to individualistic.

    After being hit by currency demonetisation, where everybody was struggling with liquidity crunches, the mobile payment companies were the one making profit, according to Mobikwik’s Taku, who added, “Humbling and the most fortunate event of 2016  is demonetisation. We have the fortune to have been able to transform India into digital. Mobikwik has 55 million users and 1.4 million retailers in India.”

    Taku highlighted some points. In last 10-20 years, telecom has changed in India in a big way. “Till now 14 per cent of cashless transaction has been done in India post-demonetisation, which will go grow to 30 per cent by the end of 2017 and it will grow 30- 40 per cent in two years. I truly believe it’s the era of mobile wallets, and won’t deny that demonetisation has sped up the journey,” she explained.   

    ALSO READ:

    Goafest 2017: Mindshare & Maxus win big, Dainik Jagran leads publisher category